Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 1, 2020
Human intestinal enteroids as a model of Clostridioides difficile-induced enteritisMelinda A Engevik, Heather A Danhof, Alexandra L Chang-Graham, et al.
Pediatric Transplantation|October 17, 2019
Fecal microbiota transplantation in a toddler after heart transplant was a safe and effective treatment for recurrent Clostridiodes difficile infection: A case reportJoseph A Spinner, Claire E Bocchini, Ruth A Luna, et al.
Microbiome|May 2, 2017
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndromeJennifer S Labus, Emily B Hollister, Jonathan Jacobs, et al.
BMC Bioinformatics|January 17, 2013
The Genboree Microbiome Toolset and the analysis of 16S rRNA microbial sequencesKevin Riehle, Cristian Coarfa, Andrew Jackson, et al.
Annals of Surgery|July 26, 2005
Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trialRabih O Darouiche, David H Berger, Nancy Khardori, et al.
Microbiologyopen|June 30, 2016
FolC2-mediated folate metabolism contributes to suppression of inflammation by probiotic Lactobacillus reuteriCarissa M Thomas, Delphine M A Saulnier, Jennifer K Spinler, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 24, 2012
Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestineGeoffrey A Preidis, Delphine M Saulnier, Sarah E Blutt, et al.
Gut Microbes|January 22, 2019
Bacteroides ovatus ATCC 8483 monotherapy is superior to traditional fecal transplant and multi-strain bacteriotherapy in a murine colitis modelFaith D Ihekweazu, Tatiana Y Fofanova, Karen Queliza, et al.
Gut Microbes|August 18, 2020
Reuterin disrupts Clostridioides difficile metabolism and pathogenicity through reactive oxygen species generationMelinda A Engevik, Heather A Danhof, Ritu Shrestha, et al.
Multiple Sclerosis and Related Disorders|October 24, 2022
Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratiosNuman Oezguen, Vuslat Yılmaz, Thomas D Horvath, et al.
Pageof 16